Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)
Article
Wen, Patrick Y, Yung, WK Alfred, Lamborn, Kathleen R et al. (2009). Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)
. NEURO-ONCOLOGY, 11(6), 853-860. 10.1215/15228517-2009-010
Wen, Patrick Y, Yung, WK Alfred, Lamborn, Kathleen R et al. (2009). Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)
. NEURO-ONCOLOGY, 11(6), 853-860. 10.1215/15228517-2009-010
Wen, Patrick Y; Yung, WK Alfred; Lamborn, Kathleen R; Norden, Andrew D; Cloughesy, Timothy F; Abrey, Lauren E; Fine, Howard A; Chang, Susan M; Robins, H Ian; Fink, Karen; DeAngelis, Lisa M; Mehta, Minesh; Di Tomaso, Emmanuelle; Drappatz, Jan; Kesari, Santosh; Ligon, Keith L; Aldape, Ken; Jain, Rakesh K; Stiles, Charles D; Egorin, Merrill J; Prados, Michael D